The DOI matches its Crossref record.
Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“due to their large area per volume ratio, nanofibers outstand as ideal building blocks in different biomedical materials applied in drug delivery, 16 biomedical devices, 17 biosensing 18 or as dressings for wound healing.19”
From Antimicrobial Wound Dressings against Fluorescent and Methicillin-Sensitive Intracellular Pathogenic Bacteria (2020) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 56
- Elek, 1957, The virulence of Staphylococcus pyogenes for man; a study of the problems of wound infection, Br. J. Exp. Pathol., 38, 573
- Rand, 1993, Alternatives to reimplantation for salvage of the total knee arthroplasty complicated by infection, J. Bone Joint Surg. Am., 75, 282, 10.2106/00004623-199302000-00018 · doi:10.2106/00004623-199302000-00018
- Segawa, 1999, Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections, J. Bone Joint Surg. Am., 81, 1434, 10.2106/00004623-199910000-00008 · DOI · Paper page
- Giulieri, 2004, Management of infection associated with total hip arthroplasty according to a treatment algorithm, Infection, 32, 222, 10.1007/s15010-004-4020-1 · DOI · Paper page
- Mader, 1993, Antimicrobial treatment of osteomyelitis, Clin. Orthop. Relat. Res., 87
- Hanssen, 2004, Practical applications of antibiotic-loaded bone cement for treatment of infected joint replacements, Clin. Orthop. Relat. Res., 427, 79, 10.1097/01.blo.0000143806.72379.7d · doi:10.1097/01.blo.0000143806.72379.7d
- Ambrose, 2004, Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model, Clin. Orthop. Relat. Res., 293, 10.1097/01.blo.0000126303.41711.a2 · DOI
- Kanellakopoulou, 2000, Carrier systems for the local delivery of antibiotics in bone infections, Drugs, 59, 1223, 10.2165/00003495-200059060-00003 · DOI · Paper page
- Baker, 1988, Release of gentamicin from acrylic bone cement. Elution and diffusion studies, J. Bone Joint Surg. Am., 70, 1551, 10.2106/00004623-198870100-00015 · DOI · Paper page
- Levin, 1975, The effectiveness of various antibiotics in methyl methacrylate, J. Bone Joint Surg. Br., 57, 234, 10.1302/0301-620X.57B2.234 · DOI
- Mader, 1997, In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmethacrylate beads, Antimicrob. Agents Chemother., 41, 415, 10.1128/AAC.41.2.415 · doi:10.1128/aac.41.2.415
- van de Belt, 2000, Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release, Biomaterials, 21, 1981, 10.1016/S0142-9612(00)00082-X · DOI · Paper page
- Kendall, 1996, Persistence of bacteria on antibiotic loaded acrylic depots. A reason for caution, Clin. Orthop. Relat. Res., 273, 10.1097/00003086-199608000-00034 · doi:10.1097/00003086-199608000-00034
- Berman, 1984, Thermally induced bone necrosis in rabbits. Relation to implant failure in humans, Clin. Orthop. Relat. Res., 284
- Campoccia, 2006, The significance of infection related to orthopedic devices and issues of antibiotic resistance, Biomaterials, 27, 2331, 10.1016/j.biomaterials.2005.11.044 · DOI · Paper page
- Yang, 2009, PLGA and PHBV microsphere formulations and solid-state characterization: possible implications for local delivery of fusidic acid for the treatment and prevention of orthopaedic infections, Pharm. Res., 26, 1644, 10.1007/s11095-009-9875-5 · DOI
- You, 2005, In vitro degradation behavior of electrospun polyglycolide, polylactide, and poly(lactide-co-glycolide), J. Appl. Polym. Sci., 95, 193, 10.1002/app.21116 · DOI · Paper page
- Reneker, 1996, Nanometre diameter fibers of polymer, produced by electrospinning, Nanotechnology, 7, 216, 10.1088/0957-4484/7/3/009 · DOI · Paper page
- Reneker, 2000, Bending instability of electrically charged liquid jets of polymer solutions in electrospinning, J. Appl. Phys., 87, 4531, 10.1063/1.373532 · DOI · Paper page
- Boland, 2004, Electrospinning collagen and elastin: preliminary vascular tissue engineering, Front. Biosci., 9, 1422, 10.2741/1313 · DOI · Paper page
- Yoshimoto, 2003, A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering, Biomaterials, 24, 2077, 10.1016/S0142-9612(02)00635-X · DOI · Paper page
- Yang, 2005, Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering, Biomaterials, 26, 2603, 10.1016/j.biomaterials.2004.06.051 · DOI · Paper page
- Sahoo, 2006, Characterization of a novel polymeric scaffold for potential application in tendon/ligament tissue engineering, Tissue Eng., 12, 91, 10.1089/ten.2006.12.91 · DOI · Paper page
- Katti, 2004, Bioresorbable nanofiber-based systems for wound healing and drug delivery: optimization of fabrication parameters, J. Biomed. Mater. Res. B Appl. Biomater., 70, 286, 10.1002/jbm.b.30041 · DOI · Paper page
- Zeng, 2003, Biodegradable electrospun fibers for drug delivery, J. Control. Release, 92, 227, 10.1016/S0168-3659(03)00372-9 · DOI · Paper page
- Torres-Giner, 2012, Controlled Delivery of Gentamicin Antibiotic from Bioactive Electrospun Polylactide-Based Ultrathin Fibers, Adv. Eng. Mater., 14, 10.1002/adem.201180006 · DOI
- Said, 2012, Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing, Eur. J. Pharm. Biopharm., 80, 85, 10.1016/j.ejpb.2011.08.007 · DOI
- Said, 2011, Antimicrobial PLGA ultrafine fibers: interaction with wound bacteria, Eur. J. Pharm. Biopharm., 79, 108, 10.1016/j.ejpb.2011.03.002 · DOI
- Weber, 1983, High-pressure liquid chromatographic quantitation of rifampin and its two major metabolites in urine and serum, Rev. Infect. Dis., 5, S433, 10.1093/clinids/5.Supplement_3.S433 · doi:10.1093/clinids/5.supplement_3.s433
- McFarland, 1907, The nephelometer: an instrument for estimating the number of bacteria in suspension used for calculating the opsonic index and for vaccines, JAMA, XLIX, 1176, 10.1001/jama.1907.25320140022001f · DOI · Paper page
- Chakraborty, 2009, Electrohydrodynamics: a facile technique to fabricate drug delivery systems, Adv. Drug Deliv. Rev., 61, 1043, 10.1016/j.addr.2009.07.013 · DOI · Paper page
- Xie, 2006, Electrospun micro- and nanofibers for sustained delivery of paclitaxel to treat C6 glioma in vitro, Pharm. Res., 23, 1817, 10.1007/s11095-006-9036-z · DOI · Paper page
- Farber, 1986, Interaction between rifampin and fusidic acid against methicillin-resistant coagulase-positive and -negative staphylococci, Antimicrob. Agents Chemother., 30, 174, 10.1128/AAC.30.1.174 · doi:10.1128/aac.30.1.174
- Xu, 2008, The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsion-electrospinning, Eur. J. Pharm. Biopharm., 70, 165, 10.1016/j.ejpb.2008.03.010 · DOI · Paper page
- Perlroth, 2008, Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature, Arch. Intern. Med., 168, 805, 10.1001/archinte.168.8.805 · DOI · Paper page
- Regar, 2001, Stent development and local drug delivery, Br. Med. Bull., 59, 227, 10.1093/bmb/59.1.227 · DOI · Paper page
- Ravivarapu, 2000, Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate, J. Pharm. Sci., 89, 732, 10.1002/(SICI)1520-6017(200006)89:6<732::AID-JPS4>3.0.CO;2-D · doi:10.1002/(sici)1520-6017(200006)89:6<732::aid-jps4>3.0.co;2-d
- Taepaiboon, 2007, Vitamin-loaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin E, Eur. J. Pharm. Biopharm., 67, 387, 10.1016/j.ejpb.2007.03.018 · DOI · Paper page
- Fong, 1999, Beaded nanofibers formed during electrospinning, Polymer, 40, 4585, 10.1016/S0032-3861(99)00068-3 · DOI · Paper page
- Verreck, 2003, Incorporation of drugs in an amorphous state into electrospun nanofibers composed of a water-insoluble, nonbiodegradable polymer, J. Control. Release, 92, 349, 10.1016/S0168-3659(03)00342-0 · DOI · Paper page
- Cui, 2006, Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetamol inoculation, Biomacromolecules, 7, 1623, 10.1021/bm060057z · DOI · Paper page
- Srikar, 2008, Desorption-limited mechanism of release from polymer nanofibers, Langmuir, 24, 965, 10.1021/la702449k · DOI · Paper page
- Carey, 1971, Micellar properties of sodium fusidate, a steroid antibiotic structurally resembling the bile salts, J. Lipid Res., 12, 604, 10.1016/S0022-2275(20)39480-3 · doi:10.1016/s0022-2275(20)39480-3
- Li, 2009, Distribution of Sorbitan Monooleate in poly(l-lactide-co-varepsilon-caprolactone) nanofibers from emulsion electrospinning, Colloids Surf., B Biointerfaces, 69, 221, 10.1016/j.colsurfb.2008.11.031 · doi:10.1016/j.colsurfb.2008.11.031
- Owen, 2010, An in vitro study of plasticized poly(lactic-co-glycolic acid) films as possible guided tissue regeneration membranes: material properties and drug release kinetics, J. Biomed. Mater. Res. A, 95, 857, 10.1002/jbm.a.32865 · DOI
- Jackson, 2004, Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel, Int. J. Pharm., 283, 97, 10.1016/j.ijpharm.2004.06.025 · DOI
- Puppi, 2010, Poly(lactic-co-glycolic acid) electrospun fibrous meshes for the controlled release of retinoic acid, Acta Biomater., 6, 1258, 10.1016/j.actbio.2009.08.015 · DOI
- Toma, 1995, Antimicrobial activity of fusidic acid and disk diffusion susceptibility testing criteria for gram-positive cocci, J. Clin. Microbiol., 33, 1712, 10.1128/JCM.33.7.1712-1715.1995 · DOI
- Drugeon, 1994, In-vitro antibacterial activity of fusidic acid alone and in combination with other antibiotics against methicillin-sensitive and -resistant Staphylococcus aureus, J. Antimicrob. Chemother., 34, 899, 10.1093/jac/34.6.899 · DOI
- Grohs, 2003, In vitro bactericidal activities of linezolid in combination with vancomycin, gentamicin, ciprofloxacin, fusidic acid, and rifampin against Staphylococcus aureus, Antimicrob. Agents Chemother., 47, 418, 10.1128/AAC.47.1.418-420.2003 · DOI
- McCabe, 1968, Comparison of the antibacterial activity of rifampicin and other antibiotics, Am. J. Med. Sci., 256, 255, 10.1097/00000441-196810000-00007 · doi:10.1097/00000441-196810000-00007
- Soriano, 2005, In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis, Rev. Esp. Quimioter., 18, 168
- Prabhakara, 2011, Murine immune response to a chronic Staphylococcus aureus biofilm infection, Infect. Immun., 79, 1789, 10.1128/IAI.01386-10 · DOI
- Kotb, 1995, Bacterial pyrogenic exotoxins as superantigens, Clin. Microbiol. Rev., 8, 411, 10.1128/CMR.8.3.411 · DOI · Paper page
- Chau, 2009, Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome, Nat. Med., 15, 641, 10.1038/nm.1965 · DOI
- Feezor, 2003, Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria, Infect. Immun., 71, 5803, 10.1128/IAI.71.10.5803-5813.2003 · DOI · Paper page
Cited by
Haider, A., Haider, S., & Kang, I.-K. (2018) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.11.015 · Cited by 1,861
Electrospinning of polymeric nanofibers for drug delivery applications
Hu, X., Liu, S., Zhou, G., Huang, Y., Xie, Z., & Jing, X. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.018 · Cited by 1,190
Electrospun polymeric nanofibres as wound dressings: A review
Miguel, S. P., Figueira, D. R., Simões, D., Ribeiro, M. P., Coutinho, P., Ferreira, P., & Correia, I. J. (2018) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2018.05.011 · Cited by 362
Alavarse, A. C., de Oliveira Silva, F. W., Colque, J. T., da Silva, V. M., Prieto, T., Venancio, E. C., & Bonvent, J.-J. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2017.03.199 · Cited by 340
Biomedical Applications of Electrospun Nanofibers: Drug and Nanoparticle Delivery
Bhattarai, R. S., Bachu, R. D., Boddu, S. H. S., & Bhaduri, S. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010005 · Cited by 322
Metadata
- Authors
- Gilchrist, S. E., Lange, D., Letchford, K., Bach, H., Fazli, L., & Burt, H. M.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 170
- Issue
- 1
- Pages
- 64-73
- ISSN
- 0168-3659
- Cited by
- 117
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- Canadian Foundation for Innovation (CFI)
- Natural Sciences and Engineering Research Council (NSERC)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. https://app.cochat.ai/papers/10.1016/j.jconrel.2013.04.012
- The paper
- Gilchrist, S. E., Lange, D., Letchford, K., Bach, H., Fazli, L., & Burt, H. M. (2013). Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2013.04.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.